X-ray attenuation ability, otherwise known as radiopacity of a material, could be indisputably tagged as the central and decisive parameter that produces contrast in an X-ray image. Radiopaque biomaterials are vital in the healthcare sector that helps clinicians to track them unambiguously during pre and post interventional radiological procedures. Medical imaging is one of the most powerful resources in the diagnostic sector that aids improved treatment outcomes for patients. Intrinsically radiopaque biomaterials enable themselves for visual targeting/positioning as well as to monitor their fate and further provide the radiologists with critical insights about the surgical site. Moreover, the emergence of advanced real-time imaging modalities is a boon to the contemporary healthcare systems that allow to perform minimally invasive surgical procedures and thereby reduce the healthcare costs and minimize patient trauma. X-ray based imaging is one such technologically upgraded diagnostic tool with many variants like digital X-ray, computed tomography, digital subtraction angiography, and fluoroscopy. In light of these facts, this review is aimed to briefly consolidate the physical principles of X-ray attenuation by a radiopaque material, measurement of radiopacity, classification of radiopaque biomaterials, and their recent advanced applications.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d1tb01513cDOI Listing

Publication Analysis

Top Keywords

radiopaque biomaterials
12
intrinsically radiopaque
8
physical principles
8
principles x-ray
8
x-ray attenuation
8
x-ray
6
radiopaque biomaterial
4
biomaterial assortments
4
assortments short
4
short review
4

Similar Publications

Objective: Biodegradable cardiovascular stents made of thin, low atomic number metals (e.g. Zn, Mg, Fe) are now approved for clinical use.

View Article and Find Full Text PDF

3D printed biomaterial implants are revolutionizing personalized medicine for tissue repair, especially in orthopedics. In this study, a radiopaque bismuth oxide (BiO) doped polycaprolactone (PCL) composite is developed and implemented to enable the use of diagnostic X-ray technologies, especially spectral photon counting X-ray computed tomography (SPCCT), for comprehensive tissue engineering scaffold (TES) monitoring. PCL filament with homogeneous BiO nanoparticle (NP) dispersion (0.

View Article and Find Full Text PDF

Next-Gen Poly(ε-Caprolactone) Scaffolds: Non-Destructive In Vivo Monitoring and Accelerated Biodegradation.

Adv Healthc Mater

November 2024

Polymer Chemistry and Biomaterials Group, Department of Organic and Macromolecular Chemistry, Centre of Macromolecular Chemistry, Ghent University, Krijgslaan 281, Building S4, Belgie, Ghent, 9000, Belgium.

Poly(ɛ-caprolactone) (PCL) is a biocompatible, biodegradable, and highly mechanically resilient FDA-approved material (for specific biomedical applications, e.g. as drug delivery devices, in sutures, or as an adhesion barrier), rendering it a promising candidate to serve bone tissue engineering.

View Article and Find Full Text PDF

Thrombin Immobilized Hemocompatible Radiopaque Polyurethane Microspheres for Topical Blood Coagulation.

J Biomed Mater Res A

January 2025

Polymer Science and Engineering Division, CSIR-National Chemical Laboratory, Pune, India.

Over the past decade, there has been growing interest in developing microspheres for embolization procedures. However, the lack of noninvasive monitoring of the embolic agents and the occurrence of reflux phenomenon leading to unintentional occlusions has raised concerns regarding their compatibility/suitability for embolization therapy. Here we report the development of specialty microspheres having intrinsic radiopacity and surface functionality to tackle the existing complications that pave the way for more advanced solutions.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers developed new fusible microspheres for transcatheter arterial embolization (TAE) by using a multi-block copolymer that combines polyethylene glycol (PEG) and poly(ε-caprolactone) (PCL) to create elastic microspheres.
  • These microspheres are loaded with a clinical contrast agent called lipiodol, which helps lower their melting temperature, allowing them to fuse together effectively during the embolization process.
  • Testing on rabbit models showed that these microspheres caused significant ischemic necrosis and maintained radiopacity for a longer duration compared to existing commercial contrast agents, indicating their potential as a new embolic agent.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!